Pharyngeal anesthesia for endoscopic ultrasonography

JRCT ID: jRCT1061230018

Registered date:22/05/2023

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: Disease of abdominal and thoracic cavity
• Date of first enrollment: 22/05/2023
• Target sample size: 230
• Study type: Interventional
• Intervention(s): Patients will be randomly assigned to receive five squirts of lidocaine spray or placebo before sedation.

Outcome(s)

• Primary Outcome: patient- and endoscopist-reported tolerance and satisfaction with EUS.

Secondary Outcome

Amount of midazoram and pethidine.
The uumber of gag reflex during intubation
The number of gag reflex during procedure
The number of attempts at intubation of the upper esophagus sphincter
Adverse events

Key inclusion & exclusion criteria

• Age minimum: >= 18age old
• Age maximum: Not applicable
• Gender: Both
• Include criteria: Patients undergoing EUS

Exclude criteria

Age<18years.
Patient performed ERCP, EUS-FNA and esophagogastroduodenoscopy in same day.
ASA-PS 4-5.
Allergy for lidocaine, midazoram and pethidine
Pregnant woman
Past surgery or radiotherapy for Intraoral to laryngopharynx

Related Information

• Primary Sponsor: Matsumoto Kazuyuki